Skip to main content
# Title Department Research Year
441 Novel 1,2,4-triazole derivatives as apoptotic inducers targeting p53: Synthesis and antiproliferative activity Department of Pharmaceutical Organic Chemistry 2020
442 Click chemistry synthesis, biological evaluation and docking study of some novel 2′-hydroxychalcone-triazole hybrids as potent anti-inflammatory agents. Department of Pharmaceutical Organic Chemistry 2020
443 Sulpiride Gastro-retentive Floating Microsponges; Analytical study, In vitro Optimization and In vivo Characterization Department of Industrial Pharmacy 2020
444 Modulation of rifampicin-induced hepatotoxicity using poly(lactic-co-glycolic acid) nanoparticles: a study on rat and cell culture models 2020
445 Design and Synthesis of Novel Isatin-Based derivatives Targeting Cell Cycle Checkpoint Pathways as Potential Anticancer Agents Department of Medicinal Chemistry 2020
446 CK2 Inhibition, Lipophilicity and Anticancer Activity of New N1 Versus N2-Substituted Tetrabromobenzotriazole Regioisomers Department of Pharmaceutical Analytical Chemistry 2020
447 Design of “Turn On” fluorometric nanoprobe based on nitrogen doped graphene quantum dots modified with β-cyclodextrin and vitamin B6 cofactor for selective sensing of dopamine in human serum Department of Pharmaceutical Analytical Chemistry 2020
448 Novel Class of Benzimidazole-Thiazole Hybrids: The Privileged Scaffolds of Potent Anti-Inflammatory Activity with Dual Inhibition of Cyclooxygenase and 15-Lipoxygenase Enzymes Department of Pharmaceutical Organic Chemistry 2020
449 Effect of stevia aqueous extract on the antidiabetic activity of saxagliptin in diabetic rats Department of Pharmacognosy 2020
450 Factorial approach for the optimization and development of stability
indicating study of the contraceptive suspension for injection
(Depo-Provera®)
Department of Pharmaceutical Analytical Chemistry 2020